Literature DB >> 16485496

Influenza virus infection in racing greyhounds.

Kyoung-Jin Yoon, Vickie L Cooper, Kent J Schwartz, Karen M Harmon, Won-Il Kim, Bruce H Janke, Jody Strohbehn, Darcey Butts, Joe Troutman.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16485496      PMCID: PMC3367648          DOI: 10.3201/eid1112.050810

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Influenza is globally the most economically important respiratory disease in humans, pigs, horses, and fowl (). Influenza virus is known for its continuous genetic and antigenic changes, which impedes effective influenza control (,). More importantly, emergence of a new subtype by genetic reassortment or interspecies transmission is of great concern for preventing influenza epidemics and pandemics (). Recently, influenza outbreaks have occurred in species (feline and canine) that historically do not carry influenza virus (,), which alerted both regulatory and scientific communities to expansion of the host range of influenza virus. We report an outbreak of respiratory disease by influenza virus infection in Iowa racing greyhounds after influenza outbreaks in Florida in 2004. In mid-April, an influx of racing greyhounds into Iowa greyhound tracks resulted in outbreaks of respiratory disease within the track compounds. The disease was characterized by rapid onset of fever and cough, rapid respiration, and hemorrhagic nasal discharge. The illness rate was almost 100% in both racetrack compounds, although the death rate was <5%. Most affected dogs recovered, yet many died of hemorrhagic pneumonia. Therapeutic administration of broad-spectrum antimicrobial drugs reduced the severity of the disease but could not control it. Tissue samples from 4 animals that died of severe pneumonia were submitted to the Iowa State University Veterinary Diagnostic Laboratory. The animals represented 2 different racing tracks located in eastern and western Iowa. On gross examination, lungs exhibited extensive red to red-black discoloration with moderate to marked palpable firmness. Mild fibrinous pleuritis was also noted. Microscopically, lung sections were characterized by severe hemorrhagic interstitial to bronchointerstitial pneumonia. Patchy interstitial change with alveolar septal thickening, coagula of debris in alveoli, and associated atelectasis were evident. Focally extensive pyogranulomatous bronchointerstitial pneumonia with dilatation of airways by degenerate cells and debris was observed. Scattered vasculitis and vascular thrombi were apparent. Microbiologic testing for conventional viral and bacterial agents did not show any important pathogens except Streptococcus equi subsp. zooepidemicus from lung tissues of all animals examined. Two of the 4 lung samples were positive for influenza A virus by a real-time reverse transcription–polymerase chain reaction (RT-PCR) (). Viral pneumonic lesions of both lungs were positive for immunohistochemistry (IHC) with monoclonal antibody specific for the nucleoprotein of influenza A virus () and with antigen-capturing enzyme-linked immunosorbent assay (Directigen Flu A, Becton-Dickinson, Sparks, MD, USA). Bronchioalveolar lavage samples from the 2 positive lungs were also positive by RT-PCR for influenza A virus. Virus isolation was attempted; the influenza virus in canine lungs was unexpected since no influenza virus infection in dogs had been reported, except a recent communication at a meeting of veterinary diagnosticians (). A virus that was able to agglutinate rooster erythrocytes was isolated in Madin-Darby canine kidney cells from lung and bronchioalveolar lavage fluid of 1 of the 2 animals in which influenza virus was detected by IHC and RT-PCR. Isolates were determined by RT-PCR to be influenza A virus of H3 subtype. The US Department of Agriculture National Veterinary Services Laboratory (Ames, IA) subtyped the virus isolates (A/Canine/Iowa/13628/2005) as H3N8 by using hemagglutination-inhibition assay and neuraminidase-inhibition assay. Sequencing hemagglutinin (HA) and neuraminidase (NA) genes of both isolates showed 100% and 99.8% identity, respectively, between the 2 isolates. Phylogenetically, the HA gene (GenBank accession no. DQ146419) of the isolates was genetically close (96%–98% nucleotide homology) to the HA gene of recent H3N8 equine influenza viruses (). The NA gene (DQ146420) of the isolates also showed 96%–98% homology with the NA gene of recent H3N8 equine influenza viruses. Internal genes remain to be sequenced. In conclusion, recent outbreaks of hemorrhagic pneumonia and associated deaths in Iowa racing greyhounds were primarily due to infection by an H3N8 influenza virus genetically and antigenically similar to equine influenza viruses. This conclusion can be supported by a previous report of fatal hemorrhagic pneumonia by H3N8 virus infection in racing greyhounds in Florida (). The fact that greyhounds in 2 different racetracks, which are in geographically remote sites in Iowa, simultaneously died of the disease without the involvement of sick horses suggests that the influenza virus isolate is likely a canine-adapted strain and able to perpetuate and spread among dogs. While influenza virus infection was likely responsible for the disease outbreaks, the contribution that S. zooepidemicus might have made to the disease and the severity of clinical manifestations remains to be further evaluated since the bacterium has been implicated in respiratory disease and septicemia-associated problems in many different animal species (,).
  4 in total

Review 1.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

2.  A monoclonal-antibody-based immunohistochemical method for the detection of swine influenza virus in formalin-fixed, paraffin-embedded tissues.

Authors:  L L Vincent; B H Janke; P S Paul; P G Halbur
Journal:  J Vet Diagn Invest       Date:  1997-04       Impact factor: 1.279

3.  Association between respiratory disease and bacterial and viral infections in British racehorses.

Authors:  J L N Wood; J R Newton; N Chanter; J A Mumford
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Avian influenza H5N1 in tigers and leopards.

Authors:  Juthatip Keawcharoen; Kanisak Oraveerakul; Thijs Kuiken; Ron A M Fouchier; Alongkorn Amonsin; Sunchai Payungporn; Suwanna Noppornpanth; Sumitra Wattanodorn; Apiradee Theambooniers; Rachod Tantilertcharoen; Rattapan Pattanarangsan; Nlin Arya; Parntep Ratanakorn; D M E Osterhaus; Yong Poovorawan
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

  4 in total
  28 in total

1.  Mutation tryptophan to leucine at position 222 of haemagglutinin could facilitate H3N2 influenza A virus infection in dogs.

Authors:  Guohua Yang; Shoujun Li; Sherry Blackmon; Jianqiang Ye; Konrad C Bradley; Jim Cooley; Dave Smith; Larry Hanson; Carol Cardona; David A Steinhauer; Richard Webby; Ming Liao; Xiu-Feng Wan
Journal:  J Gen Virol       Date:  2013-09-01       Impact factor: 3.891

2.  Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.

Authors:  Aitor Nogales; Laura Rodriguez; Caroline Chauché; Kai Huang; Emma C Reilly; David J Topham; Pablo R Murcia; Colin R Parrish; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Intrahost evolutionary dynamics of canine influenza virus in naive and partially immune dogs.

Authors:  Karin Hoelzer; Pablo R Murcia; Gregory J Baillie; James L N Wood; Stephan M Metzger; Nikolaus Osterrieder; Edward J Dubovi; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 4.  A review of the pathology and treatment of canine respiratory infections.

Authors:  Miranda D Vieson; Pablo Piñeyro; Tanya LeRoith
Journal:  Vet Med (Auckl)       Date:  2012-06-26

5.  Mutation from arginine to lysine at the position 189 of hemagglutinin contributes to the antigenic drift in H3N2 swine influenza viruses.

Authors:  Jianqiang Ye; Yifei Xu; Jillian Harris; Hailiang Sun; Andrew S Bowman; Fred Cunningham; Carol Cardona; Kyoungjin J Yoon; Richard D Slemons; Xiu-Feng Wan
Journal:  Virology       Date:  2013-09-04       Impact factor: 3.616

6.  Identification of the source of A (H10N8) virus causing human infection.

Authors:  Yifei Xu; Huabin Cao; Hongyan Liu; Hailiang Sun; Brigitte Martin; Yulong Zhao; Qi Wang; Guangfu Deng; Jianli Xue; Yibo Zong; Jing Zhu; Feng Wen; Li-Ping Long; Sook-San Wong; Nan Zhao; Xiaoshan Fu; Ming Liao; Guoliang Hu; Richard Webby; George F Gao; Xiu-Feng Wan
Journal:  Infect Genet Evol       Date:  2014-12-27       Impact factor: 3.342

7.  Antigenic characterization of H3N2 influenza A viruses from Ohio agricultural fairs.

Authors:  Zhixin Feng; Janet Gomez; Andrew S Bowman; Jianqiang Ye; Li-Ping Long; Sarah W Nelson; Jialiang Yang; Brigitte Martin; Kun Jia; Jacqueline M Nolting; Fred Cunningham; Carol Cardona; Jianqiang Zhang; Kyoung-Jin Yoon; Richard D Slemons; Xiu-Feng Wan
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

8.  Diagnostic performance of the canine influenza A virus subtype H3N8 hemagglutination inhibition assay.

Authors:  Tara C Anderson; P Cynda Crawford; Jacqueline M Katz; Edward J Dubovi; Gabriele Landolt; E Paul J Gibbs
Journal:  J Vet Diagn Invest       Date:  2012-05       Impact factor: 1.279

9.  The K186E Amino Acid Substitution in the Canine Influenza Virus H3N8 NS1 Protein Restores Its Ability To Inhibit Host Gene Expression.

Authors:  Aitor Nogales; Caroline Chauché; Marta L DeDiego; David J Topham; Colin R Parrish; Pablo R Murcia; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

10.  Influenza A virus (H3N8) in dogs with respiratory disease, Florida.

Authors:  Sunchai Payungporn; P Cynda Crawford; Theodore S Kouo; Li-mei Chen; Justine Pompey; William L Castleman; Edward J Dubovi; Jacqueline M Katz; Ruben O Donis
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.